A 20-year-old man with visceral leishmaniasis receiving sodium stibogluconate therapy presented with left earache, skin eruptions over the left ear and side of the neck, inability to close the left eye, dribbling of saliva through the left side of the mouth, facial asymmetry with slurring of speech and hearing impairment (left ear) for two weeks. Four days later he also experienced marked unsteadiness of gait and falling towards the left while walking. Eruptions gradually subsided, pain decreased, but scars were left ( figure) .
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On examination, the patient had scanning type of dysarthia and left-sided gaze-evoked nystagmus. Corneal reflex on the left side was absent. There was lower motor neuron type of facial palsy along with loss of taste over the left half of the anterior two thirds of the tongue. The patient had left-sided neural deafness and marked gait ataxia. Heel-shin test and finger-nose test on the left side were markedly impaired. All superficial reflexes were present and plantars were flexor. Haematological, serum biochemical parameters and urinalysis were normal. Chest X-ray, electrocardiogram, computed tomography and magnetic resonance imaging of the head were also normal. The patient had visceral leishmaniasis and was receiving stibogluconate therapy. He was resident in Bihar state, an area highly endemic area for visceral leishmaniasis. He had all the important characteristics of the disease: fever, hepatosplenomegaly, anaemia and leucopenia. This disease primarily affects the lymphoreticular system, and depression of the cellular immune response is well documented. Lymphocytes from such patients, stimulated with leishmania antigen, neither produce interleukin-2 nor proliferate. The production of interferon-y, and activation of macrophages are also impaired.3 Despite significant impairment of cell-mediated immunity, increased occurrence of herpes zoster has not been reported in visceral leishmaniasis. In our patient the immunological changes may have resulted in more extensive involvement. However, in other systemic diseases affecting the immune system, increased association of zoster is well documented.3 Goffinet and co-workers3 found herpes zoster in 11.4% of lymphoma patients. An increased frequency of zoster occurred in these patients after splenectomy or chemotherapy and following radiation therapy. In another study, Schimpff and co-workers4 reported zoster in 25% of patients with Hodgkin's disease, 7% of other lymphoma patients, 1.2% of patients with acute leukaemia, and 1.8% of patients with solid tumours. The increased occurrence of herpes zoster in patients with AIDS suggests the major role of cell-mediated immunity in preventing the occurrence of the disease. Reactivation of herpes zoster is seen in 1-20% of patients with HIV infection; this is an indi- The most unusual feature in our patient was ipsilateral cerebellar involvement. Acute cerebellitis is an important and common complication of varicella infection of childhood (chicken pox). Cerebellar involvement in varicella is bilateral and self-limiting, usually resolving within two weeks.' In these children, the aetiology of cerebellar involvement (direct invasion or auto-immune reaction) is unresolved. Ipsilateral involvement of the cerebellum suggests intracranial transmission of viral infection and/or inflammation (angiitis) of vessels of the posterior circulation. The involvement of upper cervical nerves suggests that the viral infection is carried in a retrograde fashion to the vertebrobasilar arterial systems. However, as imaging studies are normal, direct invasion of ipsilateral cerebellum by herpes zoster virus is more plausible. The vestibulolabyrinthine system and connecting neurons may serve as a route of viral transmission to the cerebellum.
In the past, several cases of contralateral hemiparesis have been reported after the eruption of ophthalmic zoster; 50% of such patients were immunologically impaired and many had granulomatous angiitis of the cerebral vessels. Virus-like particles were identified in vessel walls in several autopsy studies. These studies suggested that the cerebral infarctions in association with herpes zoster were a direct result of viral invasion of cerebral vessel leading to inflammation, thrombosis and distal infarction. Angiograms showed ipsilateral segmental stenosis of the supraclinoid portion of the internal carotid artery. Extensions of the trigeminal nerve probably serve as a route of virus transmission to intracranial vessels.' 8 One of the major goals of treatment of herpes zoster is to prevent dissemination of virus. Intravenous or high-dose oral acyclovir is the treatment of choice. Immunocompromised patients with dissemination of virus and seriously ill patients with herpes zoster ophthalmicus need intravenous acyclovir. 
